{"version":"1.0","type":"link","title":"Discovery of  as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast Cancer.","author_name":"Chen D 외","author_url":"https://prs-insight.online/author/Chen%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88868","thumbnail_width":1200,"thumbnail_height":630}